CONMED Corp【CNMD】Income statement

Market cap

$1.4B

P/E ratio

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Revenue	725	767	763	740	719	764	796	860	955	862	1,011	1,045	1,245	1,307
Revenue growth (%)	-
Cost of revenue	350	361	350	336	337	355	365	391	430	402	443	474	568	574
Gross profit	375	406	412	404	382	408	431	469	525	460	568	571	676	733
Gross margin (%)
Research & development	29	28	26	28	27	32	32	42	45	40	44	47	53	54
Selling, general & administrative	277	302	311	294	303	338	352	356	400	374	415	454	503	478
Operating margin (%)
Operating income	8	65	57	53	51	38	47	71	79	46	110	70	121	200
Operating expenses	367	341	356	351	331	371	384	398	446	414	458	501	556	533
Income before tax	-2	59	51	47	45	19	29	51	31	2	73	-71	81	163
Pretax margin (%)	-0.3	7.8	6.6	6.3	6.3	2.5	3.6	5.9	3.3	0.2	7.2	-6.8	6.5	12.5
Provision for income taxes	-3	19	15	14	15	5	-27	10	3	-8	11	10	16	31
Effective tax rate (%)
Net income	1	40	36	32	30	15	55	41	29	10	63	-81	64	132
Net income margin (%)
Earnings per share	0.03	1.43	1.3	1.17	1.1	0.53	1.99	1.45	1.01	0.33	2.14	-2.68	2.1	4.29
Diluted EPS	0.03	1.41	1.28	1.16	1.09	0.52	1.97	1.41	0.97	0.32	1.94	-2.68	2.04	4.25
Dividend payout ratio (%)	-
Dividend per share	-	0.6	0.65	0.8	0.8	0.8	0.8	0.8	0.8	0.8	0.8	0.8	0.8	0.8